Great Debates and Updates in Hematologic Malignancies - February 25-27,2021

Join us virtually for a unique educational experience. In this debate-style series, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of hematology/oncology.

Through a comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

New Exclusive Session for 2021: COVID-19 Update

Which Patients with Hematologic Malignancies Should (and Shouldn't) Get a COVID-19 Vaccine and Will it Work for Them? A Focus on Lymphoma and Myeloma
How to Approach Management of Cancer and COVID-19 in Patients with Blood Cancers? A Focus on Leukemia and Myeloid Malignancies

Tickets https://go.evvnt.com/720354-2?pid=176 

Prices:
Physician, PhD, PharmD USD 279.00
Nurse Practitioner, Physician Assistant USD 169.00
Nurse, Student, Resident, Fellow USD 89.00
Pharmaceutical Industry USD 549.00

Time: On Thursday February 25, 2021 at 9:00 am (ends Saturday February 27, 2021 at 4:00 pm)